These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 5150795)

  • 1. Local diffusibility of rifampicin in tuberculous lesions of bone and joint.
    Popescu E; Algeorge G; Paunescu E; Stoinescu M; Rudescu D
    Respiration; 1971; 28():Suppl:44-51. PubMed ID: 5150795
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical studies on the effects of rifampicin for bone and joint tuberculosis (author's transl)].
    Sawamura K; Shimomura M
    Kekkaku; 1973 Aug; 48(8):357-63. PubMed ID: 4755862
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical studies on the effects of rifampicin for severe bone and joint tuberculosis].
    Otani K
    Kekkaku; 1973 Mar; 48(3):75-88. PubMed ID: 4721389
    [No Abstract]   [Full Text] [Related]  

  • 4. The concentrations of 4 antituberculous drugs in cold abscesses in patients with bone and joint tuberculosis.
    Wu QQ; Na XK; Tian WC
    Chin Med J (Engl); 1987 Oct; 100(10):819-22. PubMed ID: 3127136
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum and urine concentrations of rifampicin administered by intravenous infusion in man.
    Acocella G; Bonollo L; Mainardi M; Margaroli P; Tenconi LT
    Arzneimittelforschung; 1977; 27(6):1221-6. PubMed ID: 578447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Local therapeutic trials of various forms of extrapulmonary tuberculosis using rifampicin suspension].
    Basacopol A; Burzoni FJ; Munteanu E
    Maroc Med; 1974 May; 54(579):314-6. PubMed ID: 4444315
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of blood concentration of rifampicin between administration before and after breakfast].
    Tsukamura M; Yokouchi J; Miwa T; Koike K
    Kekkaku; 1972 Apr; 47(4):69-73. PubMed ID: 5073928
    [No Abstract]   [Full Text] [Related]  

  • 8. [Initial evaluation of the use of rifampicin in the treatment of bone and lymph node tuberculosis].
    Duriez J; Debeaumont A
    Rev Chir Orthop Reparatrice Appar Mot; 1972; 58(1):21-32. PubMed ID: 4263541
    [No Abstract]   [Full Text] [Related]  

  • 9. [Rifampicin and its clinical use].
    Fafrowicz B
    Wiad Lek; 1971 Jul; 24(3):233-8. PubMed ID: 4926926
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effects of rifampicin on bone-joint tuberculosis with fistulation].
    Kondo K; Kuze A; Usui M; Harada Y
    Kekkaku; 1973 Mar; 48(3):89-95. PubMed ID: 4721390
    [No Abstract]   [Full Text] [Related]  

  • 11. [Assessment of antituberculosis drug concentrations in cold abscesses in patients with bone and joint tuberculosis].
    Wu QQ
    Zhonghua Wai Ke Za Zhi; 1983 Aug; 21(8):483-5. PubMed ID: 6653255
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous use of rifampicin.
    Nilsson BS; Boman G
    Eur J Respir Dis; 1981 Jun; 62(3):212-4. PubMed ID: 7308336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rifampicin diffusion in non-infected human bone (author's transl)].
    Sirot J; Lopitaux R; Cluzel R; Delisle JJ; Sauvezie B
    Ann Microbiol (Paris); 1977; 128(2):229-36. PubMed ID: 931258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of meals on rifampicin absorption.
    Siegler DI; Bryant M; Burley DM; Citron KM; Standen SM
    Lancet; 1974 Jul; 2(7874):197-8. PubMed ID: 4135611
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bioavailability of 2 different rifampicin preparations].
    Aronne Benach MT; Naranjo Cascante G
    Rev Clin Esp; 1980 Oct; 159(1):43-6. PubMed ID: 7008102
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of advanced and complicated variants of osteoarticular tuberculosis with rifampin and ethambutol].
    Suleĭmanov I; Prosvirova LA; Umarov B; Beliakova NK
    Probl Tuberk; 1981 Dec; (12):49-52. PubMed ID: 7335634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Rifampicin levels in blood, urine and kidney tissue in patients with renal tuberculosis].
    Mochalova TP; Kanevskaia SS; Danilova NK
    Antibiotiki; 1973 Feb; 18(2):178-80. PubMed ID: 4776397
    [No Abstract]   [Full Text] [Related]  

  • 18. [Absorption, distribution, metabolism and excretion of rifampicin (3-(4-methyl-1-piperazinyl-iminomethyl) rifamycin SV) in the rat].
    Akimoto T; Ono K; Nanpo T
    Jpn J Antibiot; 1970 Jun; 23(3):250-6. PubMed ID: 5312377
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacokinetics of intravenous rifampicin (RMP) and its clinical evaluation in purulent bacterial meningitis].
    Di Nola F; Eandi M; Soranzo ML; Capra E; Bosio G; Bramato C; Salassa B; Bendiscioli L
    Minerva Med; 1981 Apr; 72(14):875-92. PubMed ID: 7219797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampicin, a general review.
    Binda G; Domenichini E; Gottardi A; Orlandi B; Ortelli E; Pacini B; Fowst G
    Arzneimittelforschung; 1971 Dec; 21(12):1907-77. PubMed ID: 4945790
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.